trypan blue has been researched along with Niemann-Pick Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagan, A; Darroch, PI; Gatt, S; Granot, T; He, X; Schuchman, EH | 1 |
1 other study(ies) available for trypan blue and Niemann-Pick Disease
| Article | Year |
|---|---|
A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death.
Topics: Boron Compounds; Cell Death; Cell Line; Cell Line, Tumor; Ceramides; Fibroblasts; HL-60 Cells; Humans; Hydrolysis; Jurkat Cells; Lipids; Lysosomal-Associated Membrane Protein 2; Microscopy, Fluorescence; Models, Chemical; Niemann-Pick Diseases; Phosphatidylcholines; Skin; Sphingomyelin Phosphodiesterase; Sphingomyelins; Trypan Blue | 2005 |